Clobazam Suspension
Product Images NDC 69452-116

13 FDA label images from Bionpharma Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 69452-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Stucture (Structure001)

Stucture (Structure001)
Chemical structure of Clobazam, showing a benzodiazepine core with chlorine, methyl, and phenyl substituents as part of its molecular framework.*
FDA Label Image

Graph 1 (Figure01)

Graph 1 (Figure01)
A bar graph showing percentage reduction in weekly drop seizure rate across four groups: Placebo, Low, Medium, and High doses. The reductions are -12.1% for Placebo, -41.2% for Low, -49.4% for Medium, and -68.3% for High, with asterisks denoting statistical significance at p < 0.05 and p < 0.01 for Low, Medium, and High groups compared to Placebo.*
FDA Label Image

Graph 2 (Figure02)

Graph 2 (Figure02)
A bar chart comparing the proportion of patients (%) by reduction in weekly drop seizure frequency from baseline (%) across four groups: Placebo, Clobazam Low, Clobazam Medium, and Clobazam High. The x-axis shows ranges of percentage reduction in seizures from 'Worse' to '80 to 100', while the y-axis indicates the proportion of patients. Different shading and patterns distinguish the groups.*
FDA Label Image

Figure 1 (Figure03)

Figure 1 (Figure03)
Clobazam Oral Suspension 2.5 mg/mL in a brown glass bottle with a white child-resistant cap, accompanied by a bottle adapter and two oral syringes with red plungers. The product is labeled for oral use and packaged in a white box displaying the brand name, concentration, and labeler Bionpharma Inc. The package size is 120 mL.*
FDA Label Image

Figure 2 (Figure04)

Figure 2 (Figure04)
Clobazam 2.5 mg/mL oral suspension in a brown glass bottle with a white child-resistant cap. The label indicates it is an oral suspension and includes instructions to shake well. The product is labeled by Bionpharma Inc.*
FDA Label Image

Figure 3 (Figure05)

Figure 3 (Figure05)
Illustration showing how to insert a white plastic dosing adapter or safety device into the opening of an amber glass bottle, with a downward arrow indicating the direction for insertion.*
FDA Label Image

Figure 4 (Figure06)

Figure 4 (Figure06)
An instructional diagram of an oral dosing syringe labeled with its parts: Tip, Dosage indicators on the barrel marked in milliliters (mL), Barrel, Top of the Plunger, and Plunger. The plunger is red, with a clear barrel showing volume measurements up to 10 mL.*
FDA Label Image

Figure 5 (Figure07)

Figure 5 (Figure07)
An illustration showing a hand holding a red oral dosing syringe inserted into the neck of a brown glass bottle, demonstrating how to measure and draw out liquid medication from the bottle.*
FDA Label Image

Figure 6 (Figure08)

Figure 6 (Figure08)
An instructional image demonstrating the use of a dosing syringe to measure an oral liquid medication. The syringe is marked from 1 mL to 10 mL and is shown being filled from a brown bottle. A black arrow indicates the need to pull the plunger downward to draw the liquid.*
FDA Label Image

Figure 7 (Figure09)

Figure 7 (Figure09)
An instructional image showing a dosing syringe attached to an amber bottle of oral suspension. The syringe is marked in milliliters from 1 mL to 7 mL, with a pink liquid inside. A label on the image instructs to 'Measure to top of plunger' for accurate dosing.*
FDA Label Image

Figure 8 (Figure010)

Figure 8 (Figure010)
A close-up illustration showing a young child receiving an oral liquid medication administered with a red safety syringe held by an adult's hand. The image demonstrates the method of giving an oral suspension, relevant for products like Clobazam 2.5 mg/mL oral suspension.*
FDA Label Image

Figure 9 (Figure011)

Figure 9 (Figure011)
Illustration showing hands demonstrating how to twist open the white child-resistant cap on a brown glass bottle of Clobazam Oral Suspension. The label partially visible on the bottle includes the product name and indicates this is an oral suspension.*
FDA Label Image

Carton (Image01)

Carton (Image01)
Clobazam Oral Suspension 2.5 mg/mL in a 120 mL bottle, label by Bionpharma Inc. The label states oral suspension for oral administration only, with dosage and storage instructions. It includes a barcode, prescription-only designation, and instructions to dispense the medication guide and instructions with each prescription.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.